The Institute for Continuing Healthcare Education

DermInsider26 Session 1 Best of FC25

DermInsider - Session 1

MD, MAS

thumbnail_337 GLPs in PsO DermInsider Tile Photo - PSO PHOTO.jpg

337 GLPs in PsO DermInsider Tile Photo - PSO PHOTO.jpg

Discuss the multifactorial rationale for combining interleukin (IL)-17 inhibitors with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in psoriatic disease management

Examine clinical data related to the combination of biologic therapies with GLP-1RAs in psoriatic disease management for overweight or obese patients

Describe patient selection considerations when choosing combination biologic/GLP-1RA regimens for psoriatic disease management

small_337 GLPs in PsO DermInsider Tile Photo - TITLE SLIDE.png

thumbnail_337 GLPs in PsO DermInsider Tile Photo - TITLE SLIDE.png

337 GLPs in PsO DermInsider Tile Photo - TITLE SLIDE.png

Psoriasis

On-Demand CME Videos

Best of FC25: GLP-1RAs in Psoriasis – Catching Up on The Science 

DermInsider - Session 1: Best of FC25: GLP-1RAs in Psoriasis – Catching Up on The Science: An Online Activity

DermInsider - Session 1: Best of FC25: GLP-1RAs in Psoriasis – Catching Up on The Science: An Online Activity

About

Availability

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures